weight loss injection liraglutide semaglutide
Weight Loss Injection, so-called Weight Loss Pen, is revolutionizing the way people manage their weight. H.U.M. Clinic provides weight loss injection in Bangkok, Thailand. we offer cutting-edge weight loss medications such as Semaglutide (Ozempic) and Liraglutide (Saxenda). These injectable weight loss drugs are designed to regulate appetite and promote a feeling of fullness, making them a powerful tool for achieving your weight loss goals.
H.U.M Clinic, one of the leading weight loss clinics in Bangkok, is dedicated to providing personalized care tailored to your unique needs. Whether you’re considering a weight loss injection in Bangkok for its convenience or effectiveness, or exploring other weight loss drugs, our expert team at H.U.M. Clinic will guide you through the process. Check out the Effective Weight Loss Pen Package if you are interested in the medication.
Weight loss injections, also known as GLP-1 receptor agonists, are medications designed to help individuals lose weight by regulating appetite and insulin levels. These injections are especially effective for people struggling with obesity who haven’t found success with other methods.
GLP-1 medications, such as Semaglutide (Ozempic) and Liraglutide (Saxenda), mimic hormones that reduce appetite and slow down digestion. This leads to a feeling of fullness, helping you eat less and lose weight more effectively.
  • Higher Efficacy: Injections deliver medication directly, ensuring consistent absorption and effects.
  • Longer-Lasting Effects: Some injections, like Semaglutide, require only weekly administration, offering convenience over daily pills.
  • Less Frequent Dosing: Reduces the need for daily medication adherence, making it easier for patients to stay on track.
Weight loss injections, like GLP-1 receptor agonists, offer an effective solution for managing obesity. These injections work by targeting the underlying causes of weight gain, making them a powerful tool in the fight against obesity.
  • Targeted Fat Loss: Weight loss injections help reduce body fat by promoting fat breakdown and enhancing metabolic rate.
  • Sustainable Results: Patients often experience steady, long-term fat reduction, which is crucial for maintaining a healthy weight.
  • Insulin Release and Blood Sugar Control: Upon activation, GLP-1 analogs stimulate the pancreas to release more insulin, a hormone that lowers blood sugar by allowing cells to utilize glucose for energy. This process is crucial for individuals with type 2 diabetes and contributes to the weight loss effects by improving metabolic functions.
  • Appetite Suppression: One of the hallmark features of GLP-1 analogs is their ability to curb hunger. By acting on specific receptors in the brain, these medications make individuals feel fuller sooner and longer after eating, which naturally leads to a reduction in calorie intake.
  • Slowing Gastric Emptying: GLP-1 analogs slow the movement of food from the stomach to the intestine. This not only helps in prolonging the feeling of fullness but also stabilizes blood sugar levels by preventing rapid glucose absorption after meals.
weight loss injection liraglutide
Weight loss injections, particularly GLP-1 receptor agonists, offer diverse options to cater to different needs and preferences. These medications are designed to mimic the natural GLP-1 hormone, which helps control blood sugar and appetite, aiding in effective weight management.
  • Liraglutide (Saxenda®): A daily injection used to treat both obesity and type 2 diabetes.
  • Semaglutide (Ozempic®): A once-weekly injection known for significant weight loss effects.
  • Semaglutide (Wegovy®): The original Semaglutide. Delivered weekly injection, known for its potent weight loss effects.
  • Dulaglutide (Trulicity®): Another weekly injection offering convenience and sustained results.
  • Tirzepatide (Mounjaro®): A newer injectable option primarily for type 2 diabetes, with notable weight loss benefits.
  • Semaglutide (Rybelsus®): The only GLP-1 analog available in pill form, taken daily.
In Thailand, several weight loss injections have been approved and are widely available for managing obesity. These options include Saxenda, which is specifically approved for weight loss, and Ozempic and Trulicity, both approved for diabetes management but also effective in promoting weight loss.
  • Liraglutide (Saxenda®): Specifically approved by the Thai FDA for weight loss. It’s the first weight loss injection available in Thailand, administered daily to help reduce appetite and promote weight loss.
  • Semaglutide (Ozempic®): While primarily approved for diabetic control, Ozempic is a once-weekly injection that some individuals use for weight loss. The active ingredient is the same as in Wegovy.
  • Dulaglutide (Trulicity®): Another weekly injection, approved for diabetes management. It also offers weight loss benefits, making it a convenient option for patients seeking sustained results. This medication is only available at the hospital, prescribed by Endocrinologist.
This is what happen when you have used weight loss injection, Semaglutide, Liraglutide
Weight loss injections like Saxenda (Liraglutide) and Ozempic (Semaglutide) have gained popularity due to their effectiveness in supporting significant weight loss. These medications, approved for both diabetes management and weight reduction, work by helping patients control appetite and achieve a healthy weight.
  • Liraglutide (Saxenda®): Clinical trials have shown that Liraglutide can result in an average weight loss of 5-10% of body weight over a year. The effect is when it is combined with a reduced-calorie diet and increased physical activity.1
  • Semaglutide (Ozempic®) : The participants being treated with 1 mg of Semaglutide (Ozempic) once weekly experienced an average weight loss of approximately 5% of their body weight over 30 weeks. This was significantly more than the placebo group, indicating the effectiveness of Semaglutide at this dosage for weight management in individuals with type 2 diabetes.2
  • Semaglutide (Wegowy®): In the study, Semaglutide demonstrated an even greater potential, with some patients losing up to 15% of their body weight in a year, highlighting its efficacy in both diabetes control and weight loss.3
  • Many patients report significant weight loss with these injections, often experiencing improved energy levels and better overall health. Real-life success stories underscore the positive impact these medications can have on quality of life. The overall goal is even better in particularly when used as a part of the other weight control modalities.
Main GLP-1 pens, such as Liraglutide (Saxenda), widely recognized for their effectiveness in weight management, also provide significant benefits beyond just shedding pounds. These medications contribute to better metabolic health, improved cardiovascular outcomes, and overall enhanced well-being.
  • Blood Pressure Reduction: GLP-1 pens lower blood pressure, reducing the risk of hypertension and heart-related complications.
  • Better Lipid Profile: Users often see reduced LDL (bad cholesterol) and increased HDL (good cholesterol), which support heart health.
  • Alleviation of Fatty Liver Disease: These pens help reduce the severity of non-alcoholic fatty liver disease (NAFLD), common in individuals with obesity.
  • Lower Risk of Heart Disease: By addressing obesity, high blood pressure, and poor lipid profiles, GLP-1 pens help lower the risk of developing heart disease, providing a preventive measure against cardiovascular issues.
doctor advice who cannot get semaglutide
Before starting treatment with GLP-1 weight loss pens, either Liraglutide (Saxenda) or Semaglutide (Ozempic), it’s crucial to understand the contraindications and risk factors. Knowing these precautions ensures the safety and health of individuals managing obesity through GLP-1 analog therapy.
  • Medullary Thyroid Carcinoma (MTC): Individuals with a personal or family history of MTC should avoid GLP-1 analogs due to the increased risk of thyroid tumors.
  • Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2): Those with this genetic condition, which heightens the risk of thyroid tumors, should not use GLP-1 analogs.
  • Hypersensitivity Reactions: Those with known allergies to GLP-1 analogs or their components should avoid these medications.
  • Pregnancy: GLP-1 analogs are not recommended during pregnancy due to insufficient safety data.
  • History of Pancreatitis: Patients with a history of pancreatitis should avoid GLP-1 analogs due to the potential risk of recurrence.
  • Renal Impairment: Individuals with significant kidney disease should use GLP-1 analogs cautiously, as these conditions can affect the medication’s metabolism.
Initiating treatment with GLP-1 analogs, such as weight loss injections, requires ongoing monitoring to ensure the therapy’s effectiveness and safety. This section outlines the key areas of focus during the treatment.
  • Medical Consultation: Continuous consultations with healthcare professionals help track progress and adjust the treatment plan as necessary. Discuss any emerging side effects or concerns during these visits.
  • Health History Review: A thorough review of your health history is essential, focusing on conditions like pancreatitis or thyroid disease, to ensure the treatment is appropriate.
  • Blood Tests: Regular blood tests are crucial to monitor blood sugar levels, kidney and liver function, and other vital health markers. These tests provide insights into how well the treatment is working and whether any adjustments are needed.
  • Ongoing Monitoring: Continuous monitoring by healthcare professionals ensures that the therapy remains effective and safe, with timely adjustments to dosage or strategy as required.
doctor giving a consultation about liraglutide medication
At H.U.M. Clinic, we strive to offer the best in weight management solutions, ensuring that our patients receive only authentic and effective treatments. Our clinic is committed to providing a seamless experience for those looking to manage their weight through GLP-1 injections such as Liraglutide and Semaglutide.
  • Authenticity Guaranteed: All our weight loss pens are sourced directly from reputable pharmaceutical companies, ensuring you receive genuine medication every time. They are all approved by the Thai FDA.
  • Optimal Storage Conditions: We maintain strict temperature control using specialized refrigerators to preserve the efficacy of your medication.
  • Expert Guidance and Support: Our healthcare professionals provide personalized advice, helping you choose the right weight loss pen based on your health profile and goals.
  • Convenient Access: From consultation to prescription, our clinic ensures a smooth and professional experience, making it easy for you to start your weight loss journey.
How soon can I expect to see results with a weight loss injection?

Results can vary, but many patients start noticing changes within the first few weeks. Maximum results often occur after consistent use over several months.

Can I combine weight loss injections with other weight loss methods?

Yes, weight loss injections can be combined with diet and exercise. However, it’s crucial to consult with your healthcare provider to ensure a safe and effective plan.

What happens if I miss a dose of my weight loss injection?

If you miss a dose, take it as soon as you remember. However, if it’s almost time for your next dose, skip the missed one. Do not double up to make up for the missed dose. Always follow the specific instructions provided by your healthcare provider.

How do I store my weight loss injection pen?

Weight loss injection pens such as Saxenda if unopened, should be stored in a refrigerator at the temperature specified by the manufacturer, usually between 2°C and 8°C. Avoid freezing the pen.

  1. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management <https://www.nejm.org/doi/full/10.1056/NEJMoa1411892> ↩︎
  2. Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456474/> ↩︎
  3. Once-Weekly Semaglutide in Adults with Overweight or Obesity <https://www.nejm.org/doi/full/10.1056/NEJMoa2032183> ↩︎